EEEmre Erdem

Emre Erdem

*This is an algorithmically generated author record based on publicly available information.

Emre Erdem has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Early creatinine and e-GFR changes as prognostic predictors of COVID-19 patients

    by Karatas Ahmet, Canakci Ebru, Erdem Emre, Ozturan Aykut, Kaya Yasemin, Sayim Beyza, Kaya Mervegul

    Objectives: We aimed to investigate the effects of the COVID-19 disease on kidney functions and early prognosis. Methods: All cases were divided into those discharged and exitus cases. The patients were diagnosed with acute kidney injury (AKI) according to the KDIGO criteria. Results: As a result of the ROC analysis, the patients with a creatinine value above 1.05 for day 1 and 0.975 for creatinine value on day 7 would be mortal (AUC values of 0.641 (0.569–0.714) and 0.757 (0.689–0.825), respectively). As a result of Univariate analysis; D-Dimer, Procalcitonin, BUN and creatinine values are risk factors and a one-unit increase in these values is 1.184; 1.105; It was determined that it would increase 1.024 and 1.304 times (p values 0.008; 0.007; <0.001; 0.002), respectively. Decreased in e-GFR value would increase the risk of death 1.026 (1/0.975) times (p<0.001). Conclusions: We observed the high creatinine, D-dimer, procalcitonin, ferritin, and low e-GFR levels were risk factors for severity and mortality for COVID-19 disease. While physicians and all stakeholders focus on the prognosis and mortality of the disease of COVID-19 disease, it is necessary to be thorough about kidney involvement as much as respiratory system involvement.


  • Stopping Ultrafiltration Related Blood Pressure Changes in Hemodialysis Patients

    by Ahmet Karataş, Emre Erdem

    Objective: The present study inquired the effects of stopping ultrafiltration on arterial pressure in hemodialysis patients.Methods: Our study was performed in 92 hemodialysis patients. Ultrafiltration was stopped after the 3rd hour of hemodialysis. Arterial pressure was measured in the supine position at 0, 5, and 10 minutes after ultrafiltration was stopped. Results: Systolic arterial pressure increased by a mean of 4 mm Hg and diastolic arterial pressure increased by a mean of 2 mmHg at 10 minutes after ultrafiltration was stopped. With regard to the difference between mean arterial pressure measured before dialysis and just after stopping ultrafiltration (0. minute), systolic arterial pressure increased by a means of 5 mmHg and diastolic arterial pressure increased by a mean of 2 mmHg at 10 minutes after ultrafiltration was stopped in the patients with a mean arterial pressure decrease of ≥ 10 mmHg. However, stopping ultrafiltration caused no significant changes in the systolic arterial pressure or diastolic arterial pressure of the patients with a mean arterial pressure decrease of < 10 mmHg. An important correlation was determined between systolic arterial pressure elevation after stopping ultrafiltration and age, ultrafiltration rate, duration of hemodialysis, gender in the patients with a mean arterial pressure decrease of ≥ 10 mmHg. Age and gender were the independent variables, which affected the systolic arterial pressure elevation after stopping ultrafiltration.Conclusion: In patients with a mean arterial pressure decrease of ≥ 10 mmHg, stopping ultrafiltration increases arterial pressure but this is a limited elevation. Stopping ultrafiltration related systolic arterial pressure elevation is more evident in females and in the elderly.


  • Accuracy of Sphygmanometers at Pharmacies

    by Dilek Gurgenyatagi Erdem, Emre Erdem, Melda Dilek, Turkan Aydogdu, Nevzat Selim, Feride Demiray, Aysel Sari, Tekin Akpolat

    Background/Aims: The aims of this study are to assess the reasons of using sphygmomanometers at pharmacies and to evaluate their accuracy. Methods: 135 devices (118 aneroid, 1 mercury, and 16 automated) from 125 pharmacies (located in Samsun city center) were included in the study. A non-randomized, cross-sectional design was used for the study protocol which had two parts: assessment of devices and a questionnaire about the pharmacy and present sphygmomanometer(s). Results: 40 (30%) of the 135 sphygmomanometers were inaccurate. 65 (48%) of the devices were older than 1 year and there was no correlation between the duration of the ownership of the sphygmomanometers and their inaccuracy (p > 0.05). Blood pressure measurement is a frequent practice at pharmacies. The aneroid type of sphygmomanometers was common. A limited number of devices were checked for accuracy before. The number of validated devices was low. Conclusion: Training programs for pharmacists including the accuracy of sphygmomanometers and regular checks of sphygmomanometers for accuracy will be beneficial to the community and to the subjects requesting measurement of blood pressure at the pharmacies.